arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PAVmed Inc.

PAVM
$1.69 ▼ -0.18 (-9.38%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
46 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Neutral
auto_awesome

Analytical Summary

PAVmed Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $10.6M
Dividend Yield —
Revenue Growth 450.0% ↗
Op. Margin —
ROIC -20.0% →
FCF / Share $-0.43 ↗
Trailing P/E —
Price / Book 0.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 4, 2026.

46-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$33.00K
↑ +450.0% —
Net Income Profit after all expenses
$-5.38M
↑ +54.8% —
FCF / Share Free cash flow per share
$-0.43
↑ +74.5% —

Health Breakdown

Returns
46
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 12 years · 46 quarters